REFERENCES
- Nichols KK, Foulks GN, Bron AJ et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011; 52: 1922−1929.
- Foulks GN, Nichols KK, Bron AJ, et al. Improving awareness, identification and management of meibomian gland dysfunction. Ophthalmology 2012; 119: S1−S12.
- Schaumberg DA, Nichols JJ, Papas EB et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011; 52: 1994−2005.
- Qiao J, Yan X. Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol 2013; 7: 1797−1803.
- Geerling G, Tauber J, Baudouin C et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 2050−2064.
- Lindsley K, Matsumura S, Hatef E et al. Interventions for chronic blepharitis. Cochrane Database Syst Rev 2012; 5: CD005556.
- Prabhasawat P, Tesavibul N, Mahawong W. A randomized double‐masked study of 0.05 per cent cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Cornea 2012; 31: 1386−1393.
- Finis D, Hayajneh J, Konig C et al. Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer‐masked trial. Ocul Surf 2014; 12: 146−154.
- Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea 2016; 35: 318−322.
- Thode AR, Latkany RA. Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (MGD). Drugs 2015; 75: 1177−1185.
- Craig JP, Chen Y‐H, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2015; 56: 1965−1970.
- Molan PC. Why honey is effective as a medicine. 1 Its use in modern medicine. Bee World 1999; 80: 80−92.
- Simon A, Traynor K, Santos K et al. Medical honey for wound care‐still the 'latest resort'? Evid Based Comp Alternat Med 2009; 6: 165−173.
- Albietz JM, Lenton LM. Standardised antibacterial Manuka honey in the management of persistent post‐operative corneal oedema: a case series. Clin Exp Optom 2015; 98: 464−472.
- Mansour AM, Zein W, Haddad R et al. Bullous keratopathy treated with honey. Acta Ophthalmol Scand 2004; 82: 312−317.
- Albietz JM, Lenton LM. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea 2006; 25: 1012−1019.
- Albietz J, Lenton L. Late reactivation of herpes zoster keratitis results in band keratopathy Optom Vis Sci 2014; 91: e149−155.
- Salehi A, Jabarzare S, Neurmohamadi M et al. A double blind clinical trial on the efficacy of honey drop in vernal keratoconjunctivitis. Evid Based Comp Alternat Med 2014; 2014: 287540.
- Majtanova N, Vodrazkova E, Kurilova V et al.Complementary treatment of contact lens‐induced corneal ulcer using honey: A case report. Cont Lens Anterior Eye 2015; 38: 61−63.
- Cernak M, Majtanova N, Cernak A et al. Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery. Phytother Res 2012; 26: 613−616.
- Molan PC, Allen KL. The effect of gamma‐irradiation on the antibacterial activity of honey. J Pharm Pharmacol 1996; 48: 1206−1209.
- Tomlinson A, Bron AJ, Korb DR et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011; 52: 2006−2049.
- Johnson ME, Murphy PJ. Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. Invest Ophthalmol Vis Sci 2007; 48: 4451−4458.
- Bron AJ, Evans VE, Smith J. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640−650.
- Jankauskiene J, Jarushaitiene D, Cheksteryte V et al. Using 20 per cent honey solution eye drops in patients with dry eye syndrome. J Apicult Res Bee World 2007; 46: 232−235.
- Schiffman RM, Christianson MD, Jacobsen G et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118: 615−621.
- Miller KL, Walt JG, Mink DR et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthamol 2010; 128: 94−101.
- Lemp MA, Crews LA, Bron AJ et al. Distribution of aqueous‐deficient and evaporative dry eye in a clinic‐based patient cohort: a retrospective study. Cornea 2012; 31: 472−478.
- Tomlinson A, Mccann LC, Pearce EI. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques. Cornea 2010; 29: 1036−1041.
- Potvin R, Makari S, Rapuano CJ. Tear film osmolarity and dry eye disease: a review of the literature. Clin Ophthalmol 2015; 9: 2039−2047.
- Golebiowski B, Papas E, Stapleton F. Assessing the sensory function of the ocular surface: implications of use of a non‐contact air jet aesthesiometer versus the Cochet‐Bonnet aesthesiometer. Exp Eye Res 2011; 92: 408−413.
- Sambursky R, Tauber S, Friedberg M et al. Sensitivity and specificity of a point‐of‐care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 2013; 131: 24−28.
- Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt 2001; 21: 17−29.
- Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification and grading. Ocular Surf 2003; 1: 107−126.
- Knop E, Knop N, Millar T e al. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology and Pathophysiology of the Meibomian Gland. Invest Ophthalmol Vis Sci 2011; 52: 1938−1978.
- Baudouin C, Messmer EM, Aragona P et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol 2016; 100: 300−306.
- Bang LM, Buntting C, Molan P. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Altern Complement Med 2003; 9: 267−273.
- Kwakman PH, te Velde AA, de Boer L et al. How honey kills bacteria. FASEB J 2010; 24: 2576−2582.
- Adams CJ, Boult CH, Deadman BJ et al. Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 2008; 343: 651−659.
- Mavric E, Wittmann S, Barth G et al. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 2008; 52: 483−489.
- Irish J, Blair S, Carter DA. The antibacterial activity of honey derived from Australian flora. PLoS One 2011; 6: e18229.
- Henriques AF, Jenkins RE, Burton NF et al. The effect of manuka honey on the structure of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2011; 30: 167−171.
- Cooper RA, Jenkins L, Henriques AFM et al. Absence of bacterial resistance to medical‐grade manuka honey. Eur J Clin Microbiol Infect Dis 2010; 29: 1237−1241.
- Henriques AF, Jenkins RE, Burton NF et al. The intracellular effects of manuka honey on Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2010; 29: 45−50.
- Blair SE, Cokcetin NN, Harry EJ et al. The unusual antibacterial activity of medical‐grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Clin Microbiol Infect Dis 2009; 28: 1199−1208.
- Kwakman PHS, de Boer L, Ruyter‐spira CP et al, Vandenbroucke‐grauls CMJE, et al. Medical‐grade honey enriched with antimicrobial peptides has enhanced activity against antibiotic‐resistant pathogens. Eur J Clin Microbiol Infect Dis 2011; 30: 251−257.
- Lu J, Carter DA, Turnbull L et al. The effect of New Zealand kanuka, manuka and clover honeys on bacterial growth dynamics and cellular morphology varies according to the species. PLoS One 2013; 8: e55898.
- Alandejani T, Marsan J, Ferris W et al. Effectiveness of honey on S. aureus and P. aeruginosa biofilms. Otolaryngol Head Neck Surg 2009; 141: 114−118.
- Jervis‐bardy J, Foreman A, Bray S et al. Methylglyoxal‐infused honey mimics the anti‐Staphylococcus aureus biofilm activity of manuka honey: potential implication in chronic rhinosinusitis. Laryngoscope 2011; 121: 1104−1107.
- Kilty SJ, Duval M, Chan FT et al. Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms. Int Forum Allergy Rhinol 2011; 1: 348−350.
- Lacey N, Delaney S, Kavanagh K et al. Mite‐related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007; 157: 474−481.
- Liu J, Sheha H, Tseng SCG. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol 2010; 10: 505−510.
- Braithwaite I, Hunt A, Riley J et al. Randomised controlled trial of topical kanuka honey for the treatment of rosacea. BMJ Open 2015; 5: e007651.
- Tomblin V, Ferguson LR, Han DY et al. Potential pathway of anti‐inflammatory effect by New Zealand honeys . Int J Gen Med 2014; 7: 149−158.
- Gannabathula S, Krissansen GW, Skinner M et al. Honeybee apisimin and plant arabinogalactans in honey costimulate monocytes. Food Chem 2015; 168: 34−40.
- Leong AG, P.M. H, Harper JL. Indigenous New Zealand honeys exhibit multiple anti‐inflammatory activities. Innate Immun 2012; 18: 18459−18466.
- Aragona P, Aguennouz MH, Rania L et al. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology 2015; 122: 62−71.
- Lanza NL, Mcclellan A, Batawi H et.al. Dry eye profiles in patients with a positive elevated surface matrix metalloproteinase 9 point‐of‐care test versus negative patients. Ocul Surf 2016; 14: 216−223.
- Bashkaran K, Zunaina E, Bakiah S et al. Anti‐inflammatory and antioxidant effects of Tualang honey in alkali injury on the eyes of rabbits: experimental animal study. BMC Complement Altern Med 2011; 11: 90.
- Uwaydat S, Jha P, Tytarenko R et al. The use of topical honey in the treatment of corneal abrasions and endotoxin‐induced keratitis in an animal model. Curr Eye Res 2011; 3: 787−796.
- Majtan J. Honey: an immunomodulator in wound healing. Wound Repair Regen 2014; 22: 187−192.
- Ker‐woon C, Abd ghafar N, Hui CK et al. The effects of acacia honey on in vitro corneal abrasion wound healing model. BMC Cell Biol 2015; 16: 2.
- Tan JJ, Azmi SM, Yong YK et al. Tualang honey improves human corneal epithelial progenitor cell migration and cellular resistance to oxidative stress in vitro. PLoS One 2014; 9: e96800.
- Bilkhu PS, Naroo SA, Wolffsohn JS. Randomised masked clinical trial of the MGDRx eyebag for the treatment of meibomian gland dysfunction‐related evaporative dry eye. Br J Ophthalmol 2014; 98: 1707−1711.
- Lacroix Z, Léger S, Bitton E. Ex vivo heat retention of different eyelid warming masks. Cont Lens Anterior Eye 2015; 38: 152−156.
- Finis D, Pischel N, König C et al. Comparison of the OSDI and SPEED questionnaires for the evaluation of dry eye disease in clinical routine [in German]. Ophthalmologe 2014; 111: 1050−1056.